Overactive Bladder - Results from #30

Is there a correlation between urodynamics findings and clinical outcomes in females with idiopathic overactive bladder syndrome (OAB). February 16, 2025

New insights into the association between arthritis and overactive bladder in NHANES 2005-2020. February 16, 2025

Clinical efficacy of transcutaneous pelvic floor magnetic stimulation combined with urination training in the treatment of overactive bladder in children. February 16, 2025

Global Prevalence of Overactive Bladder: A Systematic Review and Meta-analysis. February 16, 2025

Health utility value of overactive bladder in Japanese older adults. February 9, 2025

Up-and-coming pharmacotherapeutic options for treating patients with refractory overactive bladder. February 9, 2025

Can Baseline Urodynamic Findings Predict the Outcomes and Complications of Intravesical Injections of Onabotulinum Toxin A for Overactive Bladder? February 9, 2025

Exploring the Association Between Overactive Bladder (OAB) and Cognitive decline: mediation by depression in elderly adults, a NHANES weighted analysis. January 31, 2025

Efficacy of 100-U Onabotulinumtoxin A Treatment in Female Idiopathic Overactive Bladder-A Prospective Follow-Up Study. January 31, 2025

Increased Afferent Nerve Firing Is Correlated With the Detection of Bladder Wall Micromotion in a Perfused Ex-Vivo Porcine Model. January 26, 2025

Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder. January 26, 2025

Onabotulinum Toxin A-Led Urinary Tract Infections-Should we Safeguard? A Randomized Controlled Trial. January 26, 2025

Predicting Elevated Postvoid Residual Urine Volume Following OnabotulinumtoxinA Treatment for Overactive Bladder: A Pilot Study. January 17, 2025

Association between cardiometabolic index and overactive bladder in adult American women: A cross-sectional study. January 17, 2025

Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder. January 17, 2025

Why wasn't mirabegron chosen for the first year of the CMS negotiation program? January 17, 2025

Systematic review and meta-analysis on the association of metabolic syndrome in women with overactive bladder. January 10, 2025

Trends in Medicare Coverage of Overactive Bladder Medications in the United States. January 10, 2025

Complicated Overactive Bladder Management. January 10, 2025

Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States January 3, 2025

Page 2 of 125